Semaglutide: one pathway
Semaglutide is a GLP-1 medication. It mimics the GLP-1 hormone your gut releases after eating, which slows digestion and quiets appetite. Compounded medications are not FDA-approved.
Tirzepatide: two pathways
Tirzepatide works on GLP-1 and adds a second hormone called GIP, which can affect appetite and blood sugar. Compounded medications are not FDA-approved.
So which is better?
The right choice depends on your health history, how your body responds, how you tolerate side effects, and cost. Some people do beautifully on semaglutide and never need to switch. This is exactly the kind of decision a provider is for.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Pathways | GLP-1 | GLP-1 + GIP |
| Dosing | Weekly injection | Weekly injection |
| Our price | $200 / month | $300 / month |
The bottom line
Do not overthink the starting point. Your provider recommends one based on your situation, and your medication or dose can be adjusted at follow-up visits. The goal is the result, not the label on the vial.
Curious whether this fits your situation? The eligibility check takes about two minutes, and your intake consultation is free.